{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:24:33Z","timestamp":1789698273261,"version":"4.0.1"},"reference-count":82,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01DK106400"],"award-info":[{"award-number":["K01DK106400"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10 OD025153"],"award-info":[{"award-number":["S10 OD025153"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA051008-22"],"award-info":[{"award-number":["P30 CA051008-22"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30DK129003"],"award-info":[{"award-number":["F30DK129003"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01DK106400"],"award-info":[{"award-number":["K01DK106400"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10 OD025153"],"award-info":[{"award-number":["S10 OD025153"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA051008-22"],"award-info":[{"award-number":["P30 CA051008-22"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30DK129003"],"award-info":[{"award-number":["F30DK129003"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Sodium-glucose co-transporters (SGLTs) serve to reabsorb glucose in the kidney. Recently, these transporters, mainly SGLT2, have emerged as new therapeutic targets for patients with diabetes and kidney disease; by inhibiting glucose reabsorption, they promote glycosuria, weight loss, and improve glucose tolerance. They have also been linked to cardiac protection and mitigation of liver injury. However, to date, the mechanism(s) by which SGLT2 inhibition promotes systemic improvements is not fully appreciated. Using an obese TallyHo mouse model which recapitulates the human condition of diabetes and nonalcoholic fatty liver disease (NAFLD), we sought to determine how modulation of renal glucose handling impacts liver structure and function. Apart from an attenuation of hyperglycemia, Empagliflozin was found to decrease circulating triglycerides and lipid accumulation in the liver in male TallyHo mice. This correlated with lowered hepatic cholesterol esters. Using in vivo MRI analysis, we further determined that the reduction in hepatic steatosis in male TallyHo mice was associated with an increase in nuchal white fat indicative of \u201chealthy adipose expansion\u201d. Notably, this whitening of the adipose came at the expense of brown adipose tissue. Collectively, these data indicate that the modulation of renal glucose handling has systemic effects and may be useful as a treatment option for NAFLD and steatohepatitis.<\/jats:p>","DOI":"10.3390\/ijms23105675","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T23:14:26Z","timestamp":1652915666000},"page":"5675","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Empagliflozin Treatment Attenuates Hepatic Steatosis by Promoting White Adipose Expansion in Obese TallyHo Mice"],"prefix":"10.3390","volume":"23","author":[{"given":"Ryan","family":"Kurtz","sequence":"first","affiliation":[{"name":"Department of Human Science, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3726-2170","authenticated-orcid":false,"given":"Andrew","family":"Libby","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, University of Colorado Anschutz Medical Campus, Aurora, CO 80012, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce A.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3233-047X","authenticated-orcid":false,"given":"Komuraiah","family":"Myakala","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichien","family":"Lee","sequence":"additional","affiliation":[{"name":"Department Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA"},{"name":"Center for Translational Imaging, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Knoer","sequence":"additional","affiliation":[{"name":"Department Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia N.","family":"Lo Cascio","sequence":"additional","affiliation":[{"name":"Department of Human Science, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"McCormack","sequence":"additional","affiliation":[{"name":"Department Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Human Science, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah N. D.","family":"Choos","sequence":"additional","affiliation":[{"name":"Department of Human Science, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-1096","authenticated-orcid":false,"given":"Olga","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Department Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA"},{"name":"Center for Translational Imaging, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi Z.","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3058-6332","authenticated-orcid":false,"given":"Suman","family":"Ranjit","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC 20057, USA"},{"name":"Microscopy & Imaging Shared Resources, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Albanese","sequence":"additional","affiliation":[{"name":"Department Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA"},{"name":"Center for Translational Imaging, Georgetown University Medical Center, Washington, DC 20057, USA"},{"name":"Department of Radiology, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6403-2261","authenticated-orcid":false,"given":"Moshe","family":"Levi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular & Cellular Biology, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn M.","family":"Ecelbarger","sequence":"additional","affiliation":[{"name":"Department of Medicine, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6194-5268","authenticated-orcid":false,"given":"Blythe D.","family":"Shepard","sequence":"additional","affiliation":[{"name":"Department of Human Science, Georgetown University Medical Center, Washington, DC 20057, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.bbadis.2019.05.004","article-title":"Molecular and cellular bases of diabetes: Focus on type 2 diabetes mouse model-TallyHo","volume":"1865","author":"Tamarai","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s001250051573","article-title":"Diabetes and gender","volume":"44","author":"Gale","year":"2001","journal-title":"Diabetologia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1440-1797.2007.00796.x","article-title":"Rodent models of streptozotocin-induced diabetic nephropathy","volume":"12","author":"Tesch","year":"2007","journal-title":"Nephrology"},{"key":"ref_4","unstructured":"Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., Dungan, K., Grossman, A., Hershman, J.M., Kaltsas, G., Koch, C., and Kopp, P. (2000). Nonalcoholic Fatty Liver Disease: The Overlooked Complication of Type 2 Diabetes. Endotext, MDText.com, Inc."},{"key":"ref_5","first-page":"1","article-title":"Triglyceride Metabolism in the Liver","volume":"8","author":"Cohen","year":"2017","journal-title":"Compr. Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/hep.30333","article-title":"Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis","volume":"69","author":"Farrell","year":"2019","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jceh.2019.06.003","article-title":"Antidiabetic Drugs and Statins in Nonalcoholic Fatty Liver Disease","volume":"9","author":"Kothari","year":"2019","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/j.ajkd.2008.12.031","article-title":"Glucose control by the kidney: An emerging target in diabetes","volume":"53","author":"Marsenic","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/ki.2010.509","article-title":"Glucose handling by the kidney","volume":"79","author":"Mather","year":"2011","journal-title":"Kidney Int. Suppl."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"F188","DOI":"10.1152\/ajprenal.00518.2013","article-title":"Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia","volume":"306","author":"Rieg","year":"2014","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1681\/ASN.2010030246","article-title":"SGLT2 mediates glucose reabsorption in the early proximal tubule","volume":"22","author":"Vallon","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2337\/db10-1328","article-title":"SGLT2 deletion improves glucose homeostasis and preserves pancreatic beta-cell function","volume":"60","author":"Jurczak","year":"2011","journal-title":"Diabetes"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10741-017-9665-9","article-title":"Direct cardiovascular impact of SGLT2 inhibitors: Mechanisms and effects","volume":"23","author":"Kaplan","year":"2018","journal-title":"Heart Fail. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Komiya, C., Tsuchiya, K., Shiba, K., Miyachi, Y., Furuke, S., Shimazu, N., Yamaguchi, S., Kanno, K., and Ogawa, Y. (2016). Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151511"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12933-018-0745-5","article-title":"Potential mechanisms responsible for cardioprotective effects of sodium-glucose co-transporter 2 inhibitors","volume":"17","author":"Lahnwong","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"E117","DOI":"10.1152\/ajpendo.00439.2012","article-title":"Improved glycemic control in mice lacking Sglt1 and Sglt2","volume":"304","author":"Powell","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Wang, D., Luo, Y., Wang, X., Orlicky, D.J., Myakala, K., Yang, P., and Levi, M. (2018). The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010137"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1074\/jbc.M117.779520","article-title":"SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 protein inhibition decreases renal lipid accumulation, inflammation, and the development of nephropathy in diabetic mice","volume":"292","author":"Wang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.numecd.2007.01.007","article-title":"Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question","volume":"17","author":"Loria","year":"2007","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cgh.2011.12.039","article-title":"Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population","volume":"10","author":"Stepanova","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-62703-068-7_6","article-title":"The TALLYHO mouse as a model of human type 2 diabetes","volume":"933","author":"Kim","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Stewart, T.P., Mao, X., Aqqad, M.N., Uffort, D., Dillon, K.D., Saxton, A.M., and Kim, J.H. (2012). Subcongenic analysis of tabw2 obesity QTL on mouse chromosome 6. BMC Genet., 13.","DOI":"10.1186\/1471-2156-13-81"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.semnephrol.2021.06.005","article-title":"Sodium Glucose Transporter, Type 2 (SGLT2) Inhibitors (SGLT2i) and Glucagon-Like Peptide 1-Receptor Agonists: Newer Therapies in Whole-Body Glucose Stabilization","volume":"41","author":"Shepard","year":"2021","journal-title":"Semin. Nephrol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1007\/s00125-013-2973-2","article-title":"Fatty acids differentially regulate insulin resistance through endoplasm reticulum stress-mediated induction of tribbles homologue 3: A potential link between dietary fat composition and the pathophysiological outcomes of obesity","volume":"56","author":"Geng","year":"2013","journal-title":"Diabetologia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1194\/jlr.M063511","article-title":"SphK1 mediates hepatic inflammation in a mouse model of NASH induced by high saturated fat feeding and initiates proinflammatory signaling in hepatocytes","volume":"56","author":"Geng","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.nutres.2015.06.012","article-title":"Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL\/6 mice","volume":"35","author":"Geng","year":"2015","journal-title":"Nutr. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2217\/fca-2020-0192","article-title":"Canagliflozin: Metabolic, cardiovascular and renal protection","volume":"17","author":"Barrios","year":"2021","journal-title":"Future Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1007\/s00125-016-4008-2","article-title":"The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes","volume":"59","author":"Cherney","year":"2016","journal-title":"Diabetologia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_32","first-page":"1094","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"374","author":"Zinman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clinimag.2013.09.006","article-title":"Diagnosis of acute cholecystitis: Value of contrast agent in the gallbladder and cystic duct on Gd-EOB-DTPA enhanced MR cholangiography","volume":"38","author":"Choi","year":"2014","journal-title":"Clin. Imaging"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2337\/db18-0525","article-title":"Dynamic Contrast-Enhanced MRI of OATP Dysfunction in Diabetes","volume":"68","author":"Parys","year":"2019","journal-title":"Diabetes"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2012.01.031","article-title":"Primovist, Eovist: What to expect?","volume":"57","author":"Pastor","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.bbalip.2010.08.011","article-title":"Modulation of lipid droplet size and lipid droplet proteins by trans-10,cis-12 conjugated linoleic acid parallels improvements in hepatic steatosis in obese, insulin-resistant rats","volume":"1801","author":"Stringer","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41576-021-00414-z","article-title":"The genetics of obesity: From discovery to biology","volume":"23","author":"Loos","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s12035-020-02142-7","article-title":"Mitochondria-Targeted Small Peptide, SS31 Ameliorates Diabetes Induced Mitochondrial Dynamics in Male TallyHO\/JngJ Mice","volume":"58","author":"Bhatti","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1210\/en.2014-1041","article-title":"Early-onset type 2 diabetes impairs skeletal acquisition in the male TALLYHO\/JngJ mouse","volume":"155","author":"Devlin","year":"2014","journal-title":"Endocrinology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/jre.12041","article-title":"Experimental periodontitis induced by Porphyromonas gingivalis does not alter the onset or severity of diabetes in mice","volume":"48","author":"Li","year":"2013","journal-title":"J. Periodontal. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0031-9384(75)90075-X","article-title":"Renal deficiency associated with diabetes insipidus in the SWR\/J mouse","volume":"14","author":"Kutscher","year":"1975","journal-title":"Physiol. Behav."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"483238","DOI":"10.1155\/2015\/483238","article-title":"Sex-differences in renal expression of selected transporters and transcription factors in lean and obese Zucker spontaneously hypertensive fatty rats","volume":"2015","author":"Babelova","year":"2015","journal-title":"J. Diabetes Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/JME-11-0007","article-title":"Sex-dependent hepatic transcripts and metabolites in the development of glucose intolerance and insulin resistance in Zucker diabetic fatty rats","volume":"47","author":"Gustavsson","year":"2011","journal-title":"J. Mol. Endocrinol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/oby.2009.273","article-title":"Sex differences in high-fat diet-induced obesity, metabolic alterations and learning, and synaptic plasticity deficits in mice","volume":"18","author":"Hwang","year":"2010","journal-title":"Obesity"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1073\/pnas.0602956103","article-title":"Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice","volume":"103","author":"Chu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Pettersson, U.S., Walden, T.B., Carlsson, P.O., Jansson, L., and Phillipson, M. (2012). Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046057"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"F456","DOI":"10.1152\/ajprenal.00249.2019","article-title":"Sex Differences in Diabetes and Kidney Disease: Mechanisms and Consequences","volume":"317","author":"Shepard","year":"2019","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2891-8-11","article-title":"Differential susceptibility to obesity between male, female and ovariectomized female mice","volume":"8","author":"Hong","year":"2009","journal-title":"Nutr. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cellimm.2015.01.018","article-title":"Estrogen receptors regulate innate immune cells and signaling pathways","volume":"294","author":"Kovats","year":"2015","journal-title":"Cell Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.diabres.2017.07.012","article-title":"Sex and gender differences in therapy of type 2 diabetes","volume":"131","author":"Harreiter","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/DMSO.S184437","article-title":"Canagliflozin review-safety and efficacy profile in patients with T2DM","volume":"12","author":"Jakher","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1185\/03007995.2014.890925","article-title":"Genital mycotic infections with canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus: A pooled analysis of clinical studies","volume":"30","author":"Nyirjesy","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1574886311666160405110515","article-title":"Generalized Intense Pruritus During Canagliflozin Treatment: Is it an Adverse Drug Reaction?","volume":"13","author":"Vasapollo","year":"2018","journal-title":"Curr. Drug Saf."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1210\/en.2019-00266","article-title":"Immune Cells Gate White Adipose Tissue Expansion","volume":"160","author":"Cox","year":"2019","journal-title":"Endocrinology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/1573399810602040367","article-title":"Metabolic obesity: The paradox between visceral and subcutaneous fat","volume":"2","author":"Hamdy","year":"2006","journal-title":"Curr. Diabetes Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1007\/s00125-012-2639-5","article-title":"The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk","volume":"55","author":"Kaess","year":"2012","journal-title":"Diabetologia"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jcmg.2012.11.021","article-title":"Visceral and subcutaneous fat quality and cardiometabolic risk","volume":"6","author":"Rosenquist","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"102227","DOI":"10.1016\/j.isci.2021.102227","article-title":"LIFR-alpha-dependent adipocyte signaling in obesity limits adipose expansion contributing to fatty liver disease","volume":"24","author":"Guo","year":"2021","journal-title":"iScience"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.isci.2019.05.020","article-title":"Loss of Adipose Growth Hormone Receptor in Mice Enhances Local Fatty Acid Trapping and Impairs Brown Adipose Tissue Thermogenesis","volume":"16","author":"Ran","year":"2019","journal-title":"iScience"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41580-021-00350-0","article-title":"The cellular and functional complexity of thermogenic fat","volume":"22","author":"Cohen","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/jmri.27340","article-title":"Measuring Brown Fat Using MRI and Implications in the Metabolic Syndrome","volume":"54","author":"Yu","year":"2021","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Yau, W.W., and Yen, P.M. (2020). Thermogenesis in Adipose Tissue Activated by Thyroid Hormone. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21083020"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Szekeres, Z., Toth, K., and Szabados, E. (2021). The Effects of SGLT2 Inhibitors on Lipid Metabolism. Metabolites, 11.","DOI":"10.3390\/metabo11020087"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ebiom.2017.05.028","article-title":"SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice","volume":"20","author":"Xu","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_66","first-page":"121","article-title":"Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization","volume":"7","author":"Xu","year":"2018","journal-title":"Adipocyte"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1172\/JCI63888","article-title":"Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes","volume":"122","author":"Russo","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmet.2019.03.011","article-title":"Identification of functional lipid metabolism biomarkers of brown adipose tissue aging","volume":"24","author":"Gohlke","year":"2019","journal-title":"Mol. Metab."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients with Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2337\/dc06-0455","article-title":"Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes","volume":"29","author":"Toledo","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clnu.2020.04.033","article-title":"Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet","volume":"40","author":"Coia","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1074\/jbc.RA119.011913","article-title":"Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet-fed mice","volume":"295","author":"Takahashi","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm879","article-title":"Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation","volume":"9","author":"Brown","year":"2003","journal-title":"Nat Med"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2009.12.009","article-title":"Fibrillar Collagen Scoring by Second Harmonic Microscopy: A New Tool in the Assessment of Liver Fibrosis","volume":"52","author":"Gailhouste","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"13378","DOI":"10.1038\/srep13378","article-title":"Imaging Fibrosis and Separating Collagens Using Second Harmonic Generation and Phasor Approach to Fluorescence Lifetime Imaging","volume":"5","author":"Ranjit","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1364\/OE.15.004054","article-title":"Second Harmonic Imaging and Scoring of Collagen in Fibrotic Tissues","volume":"15","author":"Strupler","year":"2007","journal-title":"Opt. Express"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"116023","DOI":"10.1117\/1.JBO.17.11.116023","article-title":"Deep tissue fluorescence imaging and in vivo biological applications","volume":"17","author":"Crosignani","year":"2012","journal-title":"J. Biomed. Opt."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jemt.22354","article-title":"A deep tissue fluorescence imaging system with enhanced SHG detection capabilities","volume":"77","author":"Crosignani","year":"2014","journal-title":"Microsc. Res. Tech."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1364\/BOE.7.003747","article-title":"Imaging in turbid media: A transmission detector gives 2-3 order of magnitude enhanced sensitivity compared to epi-detection schemes","volume":"7","author":"Dvornikov","year":"2016","journal-title":"Biomed. Opt. Express"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1364\/BOE.7.003519","article-title":"Characterizing fibrosis in UUO mice model using multiparametric analysis of phasor distribution from FLIM images","volume":"7","author":"Ranjit","year":"2016","journal-title":"Biomed. Opt. Express"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.kint.2016.06.030","article-title":"Label-free fluorescence lifetime and second harmonic generation imaging microscopy improves quantification of experimental renal fibrosis","volume":"90","author":"Ranjit","year":"2016","journal-title":"Kidney Int."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nprot.2013.055","article-title":"Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease","volume":"8","author":"Mehlem","year":"2013","journal-title":"Nat. Protoc."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/10\/5675\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:14:27Z","timestamp":1760138067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/10\/5675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":82,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["ijms23105675"],"URL":"https:\/\/doi.org\/10.3390\/ijms23105675","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]}}}